Simplify Your Sera with MARS

With just a few protein comprising 85% to 90% of human serum, low-abundance components can be difficult to identify by mass spectrometry.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Courtesy of Agilent Technologies

With just a few protein comprising 85% to 90% of human serum, low-abundance components can be difficult to identify by mass spectrometry. Palo Alto, Calif.-based Agilent Technologies http://www.agilent.com reduces this proteomic complexity with its new, high-capacity Multiple Affinity Removal System (MARS), which removes up to 99% of the six most-abundant proteins from human plasma or serum.

Agilent has optimized the chemistry used to bind the antibodies to the beads, allowing more protein-binding sites to be exposed, explains spokesperson William Barrett. Up to 100 microliters of serum can be cleared per 4.6 mm x 100 mm column, effectively doubling the capacity (previously, the same column could process 30–40 ml).

Beta-tester Tasso Miliotis, associate principal scientist at AstraZeneca, says the high loading capacity allows more plasma to be injected per run, improving the downstream detection of low-abundance proteins. "Previously we had to make triplicate injections of the same ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Josh Roberts

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences